Back to search
FDAFDA · Food and drugs·Recall number Z-0955-2023

COVIDIEN Emprint Ablation Catheter with Thermosphere Technology, Bronchoscopic Ablation, REF CA108L1

Published January 18, 2023 · Recall initiated: November 23, 2022

Summary

FDA records medical device Class II recall Z-0955-2023, published January 18, 2023 and initiated November 23, 2022. Recalling firm: Covidien, LLC; Status: Ongoing; Reported quantity: 21 units; Lot: UDI/DI (GTIN): 10884521825765, Lot Number: 520200. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The product is labeled with the incorrect expiration date.

What to do

Voluntary: Firm initiated · Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Covidien, LLC
Distributor
Foreign Distribution: Hong Kong
Lot
UDI/DI (GTIN): 10884521825765, Lot Number: 520200
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was COVIDIEN Emprint Ablation Catheter with Thermosphere Technology, Bronchoscopic Ablation, REF CA108L1 recalled?

Yes. FDA published recall Z-0955-2023 on January 18, 2023. Reported hazard: The product is labeled with the incorrect expiration date.

What should I do if I have this product?

Voluntary: Firm initiated · Visit